Revvity Inc (RVTY)
101.08
-1.52
(-1.48%)
USD |
NYSE |
May 02, 16:00
101.08
0.00 (0.00%)
Pre-Market: 20:00
Revvity Cash from Financing (TTM): -868.95M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -868.95M |
December 31, 2023 | -947.12M |
September 30, 2023 | -1.004B |
June 30, 2023 | -483.80M |
March 31, 2023 | -610.13M |
December 31, 2022 | -661.80M |
September 30, 2022 | -724.13M |
June 30, 2022 | 2.097B |
March 31, 2022 | 2.194B |
December 31, 2021 | 2.942B |
September 30, 2021 | 3.154B |
June 30, 2021 | 242.76M |
March 31, 2021 | 404.71M |
December 31, 2020 | -202.87M |
September 30, 2020 | -527.50M |
June 30, 2020 | -201.43M |
March 31, 2020 | 120.30M |
December 31, 2019 | 150.13M |
September 30, 2019 | 344.06M |
June 30, 2019 | 64.90M |
March 31, 2019 | -187.00M |
December 31, 2018 | -179.23M |
September 30, 2018 | 694.72M |
June 30, 2018 | 788.07M |
March 31, 2018 | 811.43M |
Date | Value |
---|---|
December 31, 2017 | 782.24M |
September 30, 2017 | -96.82M |
June 30, 2017 | -21.34M |
March 31, 2017 | -83.50M |
December 31, 2016 | -115.01M |
September 30, 2016 | -67.35M |
June 30, 2016 | -171.16M |
March 31, 2016 | -130.14M |
December 31, 2015 | -107.14M |
September 30, 2015 | 62.20M |
June 30, 2015 | 59.20M |
March 31, 2015 | 17.79M |
December 31, 2014 | 30.93M |
September 30, 2014 | -139.12M |
June 30, 2014 | -159.87M |
March 31, 2014 | -123.11M |
December 31, 2013 | -154.16M |
September 30, 2013 | -126.62M |
June 30, 2013 | -66.30M |
March 31, 2013 | -76.56M |
December 31, 2012 | -44.16M |
September 30, 2012 | 363.22M |
June 30, 2012 | 199.58M |
March 31, 2012 | 390.82M |
December 31, 2011 | 397.20M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.004B
Minimum
Sep 2023
3.154B
Maximum
Sep 2021
274.07M
Average
-68.27M
Median
Cash from Financing (TTM) Benchmarks
Agilent Technologies Inc | -1.153B |
Bruker Corp | -193.40M |
Azenta Inc | -452.51M |
Harvard Bioscience Inc | -12.13M |
Bionano Genomics Inc | 113.82M |